Skip to main content
×
Login
Submit a Manuscript
Home
Journal
Current Issue
Archive
For Authors
Column Series
Research & Insight
Special Reports
Subscribe
Resources
Biosimilars Excellence Forum
Blogs
Expert Insights
Latest News
Mantle Cell Lymphoma Excellence Forum
Pathways Beyond Oncology
Topics
Comparative Effectiveness Research
Cost-Effectiveness Research
COVID-19 Updates
Guideline Updates
Health Economics and Outcomes Research
Health Technology
Real-World Data
Reimbursement
Value-Based Care
Specialties
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
B-Cell Lymphoma
Biosimilars
Bladder Cancer
Breast Cancer
CAR-T Therapies
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Cancer
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Immuno-Oncology
Kidney Cancer
Liver Cancer
Lung Cancer
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Skin Cancer
Supportive Care
Conferences
Oncology Clinical Pathways Congress
ASCO Gastrointestinal Cancers Symposium
ASCO Genitourinary Cancers Symposium
ASH Annual Meeting and Exposition
Oncology CME
About
About Us
Contact
Videos
Videos
Neoadjuvant Immune Checkpoint Inhibitors Unlikely Cost-Effective for Muscle-Invasive Bladder Cancer
February 26, 2021
Ali Khaki, MD, discusses results from a cost-effectiveness analysis comparing neoadjuvant immune checkpoint inhibition with cisplatin-based chemotherapy for muscle-invasive…
Videos
Neoadjuvant Immune Checkpoint Inhibitors Unlikely Cost-Effective for Muscle-Invasive Bladder Cancer
February 26, 2021
Ali Khaki, MD, discusses results from a cost-effectiveness analysis comparing neoadjuvant immune checkpoint inhibition…
Videos
Real-World Treatment Patterns, Survival Outcomes in Metastatic Castration-Sensitive Prostate Cancer
February 25, 2021
Stephen Freedland, MD, discusses study results exploring real-world evidence on survival outcomes among men who…
Videos
Hospital Efficiency Impact on Quality of Prostate Cancer Care
February 25, 2021
Ravi Jayadevappa, PhD, MS, discusses the association between hospital efficiency and quality of care in African…
Videos
Definitive vs Conservative Treatments for Older Men With Prostate Cancer
February 24, 2021
Sagar Patel, MD, discusses utilization trends and survival outcomes among guideline-supported treatment options in…
Videos
Enzalutamide vs Apalutamide, Darolutamide, and Bicalutamide for Nonmetastatic CRPC
February 23, 2021
Tomasz Beer, MD, discusses results from a network meta-analysis comparing the efficacy of enzalutamide vs apalutamide,…
Videos
Provider Preferences for Prostate Cancer: Medical Oncologists vs Urologists
February 21, 2021
Ajeet Gajra, FACP, MD, discusses differences in referral patterns and treatment preferences between medical oncologists…
Videos
Researchers Identify Molecular Determinants of Apalutamide Response in Nonmetastatic CRPC
February 21, 2021
Felix Feng, MD, discusses results from exploratory analysis of the phase 3 SPARTAN trial, which investigated potential…
Videos
Clinician-Facing Decision Tool to Promote Access to Prostate Cancer Clinical Trials
February 20, 2021
Hala Borno, MD, discusses observations from a research study that evaluated the implementation of a clinician-facing…
Videos
Study Finds No Correlation Between Antibiotic Use and OS in Metastatic Urothelial Carcinoma
February 19, 2021
Shilpa Gupta, MD, discusses the effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitors…
Videos
Radical Prostatectomy for Low-Risk Prostate Cancer: Incidence and Cost
February 19, 2021
David Gill, MD, discusses the incidence and cost of radical prostatectomy for NCCN low-risk prostate cancer in the…
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
››
Last page
Last »
Stay in the know.
Journal of Clinical Pathways Newsletter
Back to Top